“The private healthcare market is moving faster than many organisations realise. Investment in diagnostics and oncology is accelerating, AI is reshaping how services are delivered, and the candidate market is as active as it has been all year. Providers that move decisively on leadership, on technology, and on their talent proposition, will be the ones that capitalise on this moment.”
The UK private healthcare sector is entering a new phase of growth and transformation. Investment continues to flow into areas such as diagnostics and oncology, driven by ongoing pressure on NHS services, increasing demand from self-paying patients, and the growing use of AI across imaging and clinical pathways.
At the same time, the market for GLP-1 weight management services is evolving rapidly following the approval of an oral treatment option in the UK. We’re also seeing candidate activity across mid-level and senior management roles reach its highest level so far this year, reflecting growing confidence and movement across the sector.
Taken together, these trends suggest a market that is actively evolving. For organisations looking to capitalise on these opportunities, success will depend on having the right leadership, talent and operational capabilities in place to support sustainable growth.
Adam Brenton, Divisional Director of Healthcare at Compass Associates, draws on the latest market intelligence to explore what these shifts mean for hiring across the sector.
Diagnostics growth with AI as both the driver and the disruptor
One trend that stands out is the significant investment we’re seeing in private diagnostic services, something that would have been difficult to imagine just a few years ago.
A major driver of this growth is, of course, AI. Attending the UKIO conference in June really brought that into focus. Across discussions on diagnostics and medical imaging, there was a clear and consistent theme: organisations are actively exploring how AI can enhance efficiency, improve patient pathways and create a competitive advantage.
AI improves workflow prioritisation by assessing the severity of diagnoses and imaging data, enabling providers to place patients at the top of the queue based on clinical urgency rather than arrival time. In oncology specifically, where speed of diagnosis is directly linked to patient outcomes, this capability is a fundamental shift in how care is delivered.
Outside of that, NHS delays continue to drive significant volume into the private sector, but AI is amplifying this trend. Providers that can offer faster, more accurate diagnostic pathways are capturing a growing share of both self-pay and insured demand. For private healthcare groups, diagnostics is fast becoming a strategic growth priority.
“At UKIO, every business in diagnostics and imaging was talking about AI. The question has shifted from whether to adopt it, to how quickly you can integrate it effectively and whether you have the leaders in place to do that.”
One of our clients, which operates in exclusive partnership with Compass Associates, exemplifies this growth trajectory. The business is in active expansion across the UK, with six to eight new sites expected to open, and was highlighted at UKIO as one of the sector’s most significant growth stories across Europe. Each new site requires strong, experienced leaders capable of opening, commissioning, and building out teams from the ground up. That’s a level of demand that is drawing candidates directly from competitor organisations.
Oncology is the defining growth story of 2026 so far
Private oncology is experiencing a trajectory of demand that is unlikely to ease in the near term. NHS capacity constraints, rising cancer diagnosis rates, and growing consumer willingness to fund private care are combining to create one of the most significant expansion opportunities in the sector.
Vacancy rates at some major private surgical hospital groups fell significantly over the past two years under the pressure of NHS contract changes. During that period, many of these organisations reduced their internal recruitment and operational capacity. Now, as vacancies begin to rise again, they face a structural challenge: the infrastructure required to hire at pace was scaled back precisely when it is most needed.
Acute healthcare vacancies in the private sector are currently at their highest level in two years. A key driver is improved retention within the NHS following recent pay settlements, which has reduced the flow of clinical talent moving across into independent healthcare, tightening an already competitive candidate market.
At the same time, with oncology and diagnostics expanding at pace, providers are opening new services and sites and competing hard for experienced clinical and operational leaders to staff them. The combined effect of a more stable NHS workforce and rising private sector demand is a vacancy landscape more competitive than at any point in the last two years.
The organisations that will move quickest are those that have maintained their recruitment partnerships and can access strong clinical and operational talent rapidly. For those entering this growth phase without that infrastructure, the lead times required to source, appoint, and onboard senior leaders will be a meaningful constraint on how quickly growth ambitions can be realised.
How is AI adoption changing the talent landscape?
The relationship between AI and healthcare talent is more nuanced than headlines suggest. In diagnostics, AI adoption is already beginning to reduce demand for junior radiologist vacancies, as providers use AI to cover bandwidth that was previously handled by entry-level clinical staff. The cost calculation is straightforward and investing in AI to manage volume is a more efficient use of capital than training junior graduates who represent a retention risk.
This does not mean clinical talent is less important, but it does mean the profile of the clinical talent that organisations are competing for is shifting. Senior clinicians with the capability to work alongside AI tools, interpret their outputs, and exercise the clinical judgement that AI cannot replicate are increasingly valued. The junior-heavy staffing model in diagnostics is quietly being rearchitected.
At the leadership level, the shift is more pronounced. New job titles are beginning to appear with regularity across our healthcare briefs: Head of AI, AI Process Manager, Digital Transformation Lead. These are not niche technology roles. They are emerging as strategic appointments within mainstream healthcare providers, sitting alongside traditional operational and clinical leadership structures.
“Businesses that are not yet having these conversations about AI leadership risk falling behind — not just in the care they can deliver, but in the kind of talent they can attract. Candidates at management level increasingly want to work for organisations that are serious about technology.”
At the clinical level, adoption has not yet filtered through significantly. The honest assessment is that the timeline for meaningful AI integration in frontline clinical roles remains uncertain. But at operator and management level, the expectation that leaders understand and can direct AI strategy is already here.
Internal promotion is both an opportunity and risk
Data from our client and candidate conversations over the past quarter shows that internal promotion has become the primary driver of management vacancies across healthcare. Organisations promote from within to fill senior roles, which creates vacancy further down the structure, and so the cycle continues. It is a pattern that reflects genuine confidence in internal talent pipelines, however it can carry real risk if not managed carefully.
The most significant risk is the absence of external benchmarking. When senior appointments are made without reference to the broader market, organisations can inadvertently build leadership teams that are skilled and committed but narrowly informed. The fresh perspectives, sector cross-pollination, and challenge that external hires bring are lost. Over time, this can create skills gaps, slow down innovation, and leave succession planning fragile.
The question we are increasingly posing to clients is not whether to promote internally, but whether internal promotion decisions are being made with full visibility of what the external market can offer. The two are not mutually exclusive. The strongest organisations do both: they develop internal talent while maintaining an active understanding of the external landscape, ensuring that when the balance tips too far in one direction, they can course-correct quickly
GLP-1 is creating a new growth area
The recent UK approval of an oral GLP-1 weight loss treatment marks an important development for private healthcare providers operating in this space.
Until now, injectable treatments have dominated the market, but for some patients, the prospect of self-administering injections has been a barrier to treatment. The introduction of a tablet option has the potential to make these therapies more accessible and appealing to a broader patient population.
As a result, many providers will be watching closely to see how demand evolves. If adoption follows expectations, the availability of an oral alternative could significantly expand the market for weight management services and create new opportunities for growth across the sector.
We are seeing providers responding to this by moving towards integrated service models that combine weight loss management with counselling, psychological support, and broader wellbeing services. The model being developed by organisations such as Health Harmony, which brings weight loss, counselling, and specialist services under a single umbrella is likely to become the sector standard rather than the exception.
I believe that safeguarding and clinical governance sit central to the changes and trends we are seeing. AI is being used to screen applicants based on medical history, but human gatekeepers remain essential to ensure that vulnerable populations (particularly those with eating disorders) are protected from inappropriate access. Providers like Reset Health have invested in additional staff specifically to manage this gatekeeping function. As the market grows, I would expect that demand for safeguarding-focused roles will follow.
The regulatory environment is also in flux. The NHS is expected to introduce a market cap on private GLP-1 pricing, with suggested maximum fees in the region of £800-£900, compared to some providers currently charging up to £2,000. This intervention will reshape competitive dynamics and is likely to accelerate consolidation among providers with less efficient operating models.
Q2 candidate market is the strongest window of the year
Candidate activity is currently at its highest point across the months we have reviewed. For healthcare and social care, Q2 consistently delivers stronger candidate flow than Q1, and 2026 is proving no exception.
Senior and mid-level management candidates who received year-end bonuses in April coming typically two months after the financial year-end are now free to explore the market. Having secured their financial investment for the year and, in many cases, having completed a budget cycle or a significant period of tenure, they are more willing to move.
We have seen this directly in recent weeks, including two conversations with strong Managing Directors who collected bonuses and then chose to leave, one after five years with the same organisation. These are the kinds of candidates who are rarely visible at other points in the year.
“For hiring managers, the next six to eight weeks represent the strongest opportunity of the year to engage passive candidates. These are people who were not on the market three months ago. The organisations that move quickly and compellingly will secure them.”
Q2 also benefits from refreshed hiring budgets at the start of the financial year, providing organisations with more resource to invest in recruitment. The combination of motivated candidates and available budget creates a window that closes faster than most organisations expect.
Upcoming changes to employment law
One area it is worth paying close attention to is the new probation period legislation coming into force in January 2027. In my view, this will have significant implications for recruitment and workforce management across this sector.
Under the new framework, employees will gain substantially enhanced rights after six months of service. The practical reality is that if an employment relationship is not working, providers will need to identify and address concerns well before that six-month threshold. Delaying decisions beyond that point could expose organisations to costs equivalent to around three months’ salary, making proactive performance management more important than ever.
What advice am I giving to hiring managers within healthcare?
Build a leadership pipeline that looks beyond the next vacancy
One of the most common mistakes I see in fast-growth environments is treating recruitment as a reactive function. Organisations identify a gap, launch a search, and then realise the talent they need is not immediately available.
For senior roles in diagnostics and oncology, the sourcing phase alone typically takes at least two weeks, followed by a structured interview process of around three weeks. That means a minimum of five weeks before an offer is even made. When you then factor in notice periods of three to four months for senior hires, the full journey from initial brief to start date can easily stretch to six months.
The upcoming changes to probation period legislation only add further complexity. Providers will need to make hiring decisions earlier, assess performance more rigorously, and ensure any concerns are identified and addressed well before enhanced employee rights take effect. Combined with an already lengthy hiring cycle, this significantly increases the importance of workforce planning.
For that reason, I consistently advise organisations to begin the hiring process at least three months before a role needs to be filled where possible and much earlier for specialist or senior appointments. Candidates with immediate availability are the exception rather than the rule, and compromising on the brief simply to meet an artificial deadline rarely serves the organisation’s long-term interests.
Develop a clear position on AI and communicate it to candidates
Candidates at management and senior leadership level are increasingly evaluating potential employers on their approach to technology. Organisations that have a credible, articulated position on AI adoption are more attractive to the calibre of leaders the market is competing for. Conversely, organisations that appear uncertain or behind the curve on technology risk losing strong candidates to competitors who can demonstrate genuine digital ambition.
This does not require an organisation to be at the leading edge of AI implementation. It requires a clear narrative: what technology are we investing in, why, and what does it mean for the people who lead our services? Hiring managers who can answer those questions confidently are already at an advantage.
Treat candidate experience as a proxy for organisational culture
In a competitive market, the hiring process itself sends a signal. That means that slow processes, poor communication, and lack of transparency are among the most common reasons strong candidates disengage at the final stage. The cost of losing a high-quality hire after a significant investment in the search process is substantial – not just in time and resource, but in the damage to the organisation’s reputation in a sector where networks are tight.
Hiring managers who treat candidates with the same responsiveness, clarity, and genuine engagement they would extend to clients consistently convert more interest into commitment. Involving senior leaders early in the process, providing a realistic picture of the role’s challenges alongside its opportunities, and moving at pace when the right candidate is identified are the hallmarks of the strongest organisations we work with.
Benchmark compensation and benchmark it regularly
Salary remains important, and the competitive intensity across diagnostics, oncology, and digital health roles is increasing. Organisations that have not reviewed their pay scales and benefits packages against the current market risk losing candidates at the offer stage to organisations that have. Benchmarking should be an ongoing discipline rather than an occasional exercise, particularly in areas where new job titles and specialisms are emerging faster than internal salary bands can track.
Looking for recruitment support?
My team works closely with organisations across the sector to provide tailored advice on workforce planning, market intelligence, and talent acquisition to ensure our clients are well positioned to attract, retain, and develop the leadership they need.
If you are reviewing your hiring plans or would welcome a strategic conversation about your future workforce, we would be delighted to support you.
Looking to understand regional average pay structures in Healthcare?
Access our free benchmarking report
